![Owkin's AI model provides proof of concept that machine learning can predict gene expression across cancer types](https://cdn.cancerletter.com/media/2020/10/25180239/TCL46-41-rna_4x3.jpg)
![Owkin's AI model provides proof of concept that machine learning can predict gene expression across cancer types](https://cdn.cancerletter.com/media/2020/10/25180239/TCL46-41-rna_4x3.jpg)
Cover Story
Conversation with The Cancer Letter
Will an oncologist of the not-so-distant future be able to pull up an image of a tumor biopsy slide on a screen and—without having to order a biomarker test—see the molecular characteristics of the cancer?
By Alexandria Carolan
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Clinical Roundup
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
Drugs & Targets
![Drugs & Targets](https://cdn.cancerletter.com/media/2019/05/03161633/targets2.jpg)
![Drugs & Targets](https://cdn.cancerletter.com/media/2019/05/03161633/targets2.jpg)
Trending Stories
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Lei Zheng named executive director of Mays Cancer Center
- Supreme Court removes “Chevron deference,” threatening drug regulation, health coverage, delivery of cancer care
- Murphy, McKay, Nodora, Ballantyne, Stupack named associate directors at UCSD Moores
- Elizabeth Comen joins NYU Langone Health’s Perlmutter Cancer Center